IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ASHLEE ROBINSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1518133859
CMS profile
1089318
Location
LONDON, KY

General Payments · PY2019–2024

$1,576.09

  • Reported across 101 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$787.93

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family Medicine KY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $787.93 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $133.31 15
Lundbeck LLC $112.94 6
Novo Nordisk AS $90.52 5
Teva Pharmaceuticals USA, Inc. $87.31 5
Vanda Pharmaceuticals Inc. $84.70 4
Otsuka America Pharmaceutical, Inc. $81.48 5
Axsome Therapeutics, Inc. $46.50 2
ABBVIE INC. $35.33 2
Acerta Pharma LLC $28.88 2
Alkermes, Inc. $19.67 1
Lilly USA, LLC $18.38 1
IRONSHORE PHARMACEUTICALS INC. $18.07 1
Corcept Therapeutics $15.81 1
Merck Sharp & Dohme Corporation $15.03 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $24.18 1
PY2021 $69.46 5
PY2022 $210.83 14
PY2023 $483.69 30
PY2024 $787.93 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 1105959274 CMS
ABBVIE INC. $21.88 03/22/2024 Food and Beverage Undisputed 01/23/2026 1105959276 CMS
Alkermes, Inc. $19.67 05/23/2024 Food and Beverage Undisputed 01/23/2026 1120582594 CMS
AstraZeneca Pharmaceuticals LP $14.35 02/08/2024 Food and Beverage Undisputed 01/23/2026 1104534633 CMS
AstraZeneca Pharmaceuticals LP $14.53 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104211797 CMS
Axsome Therapeutics, Inc. $33.19 05/01/2024 Food and Beverage Undisputed 01/23/2026 1148265977 CMS
Axsome Therapeutics, Inc. $13.31 12/10/2024 Food and Beverage Undisputed 01/23/2026 1148265979 CMS
Corcept Therapeutics $15.81 10/10/2024 Food and Beverage Undisputed 01/23/2026 1117763327 CMS
IRONSHORE PHARMACEUTICALS INC. $18.07 08/08/2024 Food and Beverage Undisputed 01/23/2026 1146298490 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.60 04/27/2024 Food and Beverage Undisputed 01/23/2026 1143308246 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.08 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143308250 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.57 05/30/2024 Food and Beverage Undisputed 01/23/2026 1143308254 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.31 05/30/2024 Food and Beverage Undisputed 01/23/2026 1143308258 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.78 07/09/2024 Food and Beverage Undisputed 01/23/2026 1143308261 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.44 09/11/2024 Food and Beverage Undisputed 01/23/2026 1143308265 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.23 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143308269 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.54 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143308273 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.19 10/15/2024 Food and Beverage Undisputed 01/23/2026 1143308276 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.74 10/15/2024 Food and Beverage Undisputed 01/23/2026 1143308280 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.12 11/05/2024 Food and Beverage Undisputed 01/23/2026 1143308284 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.19 11/05/2024 Food and Beverage Undisputed 01/23/2026 1143308287 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.21 12/02/2024 Food and Beverage Undisputed 01/23/2026 1143308291 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.67 12/05/2024 Food and Beverage Undisputed 01/23/2026 1143308295 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.64 12/05/2024 Food and Beverage Undisputed 01/23/2026 1143308299 CMS
Lilly USA, LLC $18.38 02/29/2024 Food and Beverage Undisputed 01/23/2026 1136056442 CMS
Lundbeck LLC $15.92 01/06/2024 Food and Beverage Undisputed 01/23/2026 1145961930 CMS
Lundbeck LLC $18.60 01/26/2024 Food and Beverage Undisputed 01/23/2026 1145961932 CMS
Lundbeck LLC $26.64 04/23/2024 Food and Beverage Undisputed 01/23/2026 1145961934 CMS
Lundbeck LLC $17.45 06/07/2024 Food and Beverage Undisputed 01/23/2026 1145961936 CMS
Lundbeck LLC $16.04 09/13/2024 Food and Beverage Undisputed 01/23/2026 1145961938 CMS
Lundbeck LLC $18.29 12/13/2024 Food and Beverage Undisputed 01/23/2026 1145961940 CMS
Merck Sharp & Dohme LLC $15.03 04/18/2024 Food and Beverage Undisputed 01/23/2026 1141978670 CMS
Novo Nordisk Inc $17.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1096652691 CMS
Novo Nordisk Inc $20.24 05/02/2024 Food and Beverage Undisputed 01/23/2026 1097521955 CMS
Novo Nordisk Inc $18.34 08/14/2024 Food and Beverage Undisputed 01/23/2026 1097251351 CMS
Novo Nordisk Inc $14.70 12/03/2024 Food and Beverage Undisputed 01/23/2026 1097536893 CMS
Novo Nordisk Inc $20.24 12/19/2024 Food and Beverage Undisputed 01/23/2026 1097767901 CMS
Otsuka America Pharmaceutical, Inc. $18.23 02/22/2024 Food and Beverage Undisputed 01/23/2026 1118970367 CMS
Otsuka America Pharmaceutical, Inc. $15.89 03/07/2024 Food and Beverage Undisputed 01/23/2026 1118970369 CMS
Otsuka America Pharmaceutical, Inc. $14.38 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118970371 CMS
Otsuka America Pharmaceutical, Inc. $14.50 06/21/2024 Food and Beverage Undisputed 01/23/2026 1118970373 CMS
Otsuka America Pharmaceutical, Inc. $18.48 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118970375 CMS
Teva Pharmaceuticals USA, Inc. $17.70 04/19/2024 Food and Beverage Undisputed 01/23/2026 1151732101 CMS
Teva Pharmaceuticals USA, Inc. $17.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 1151732119 CMS
Teva Pharmaceuticals USA, Inc. $19.01 05/29/2024 Food and Beverage Undisputed 01/23/2026 1151732121 CMS
Teva Pharmaceuticals USA, Inc. $17.36 08/09/2024 Food and Beverage Undisputed 01/23/2026 1151732155 CMS
Teva Pharmaceuticals USA, Inc. $15.61 09/20/2024 Food and Beverage Undisputed 01/23/2026 1151732177 CMS
Vanda Pharmaceuticals Inc. $19.06 10/04/2024 Food and Beverage Undisputed 01/23/2026 1133918219 CMS
Vanda Pharmaceuticals Inc. $14.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 1133918221 CMS
Vanda Pharmaceuticals Inc. $26.82 11/22/2024 Food and Beverage Undisputed 01/23/2026 1133918223 CMS
Vanda Pharmaceuticals Inc. $24.06 12/04/2024 Food and Beverage Undisputed 01/23/2026 1133918225 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.